Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 22, 2019
Substance-P Prevents Cardiac Ischemia-Reperfusion Injury by Modulating Stem Cell Mobilization and Causing Early Suppression of Injury-Mediated InflammationHyun Sook Hong, Suna Kim, Sora Lee, et al.
The American Journal of Cardiology|May 24, 2011
Prognostic value of serial global longitudinal strain measured by two-dimensional speckle tracking echocardiography in patients with ST-segment elevation myocardial infarctionJong Shin Woo, Woo-Shik Kim, Tae-Kyung Yu, et al.
Chemico-Biological Interactions|July 12, 2020
BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagyXiao-Xiao Zhao, Haneul Cho, Sora Lee, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 21, 2021
The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative ReviewHaneul Cho, Xiao-Xiao Zhao, Sora Lee, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 10, 2009
A case of systemic amyloidosis following ankylosing spondylitis associated with congestive heart failureSang Jin Ha, Woo-Shik Kim, Seung-Joon Hwang, et al.
Heart, Lung & Circulation|October 17, 2016
Exenatide Prevents Morphological and Structural Changes of Mitochondria Following Ischaemia-Reperfusion InjuryKyung Hye Lee, Sang Jin Ha, Jong-Shin Woo, et al.
BMC Complementary and Alternative Medicine|July 13, 2017
Efficacy and safety of electroacupuncture in acute decompensated heart failure: a study protocol for a randomized, patient- and assessor-blinded, sham controlled trialJungtae Leem, Seung Min Kathy Lee, Jun Hyeong Park, et al.
American Heart Journal|December 6, 2011
Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney disease (PIANO-2 CKD) randomized studyJong Shin Woo, Weon Kim, Sul Ra Lee, et al.
Trials|August 26, 2016
Evaluation of the vascular protective effects of new oral anticoagulants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trialJin-Bae Kim, Hyun Jun Joung, Jung Myung Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2013
Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization studyJong Shin Woo, Weon Kim, Sang Jin Ha, et al.
Pageof 7